DE602005012107D1 - Pharmazeutische formulierungen mit einem antibioti - Google Patents

Pharmazeutische formulierungen mit einem antibioti

Info

Publication number: DE602005012107D1
Authority: DE; Germany
Prior art keywords: antibioti; pharmaceutical formulations; formulations; pharmaceutical
Prior art date: 2004-08-13
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

DE602005012107T

Other languages

English (en)

Inventor

Abu Huq

Allan J Weingarten

Robert D Simmons

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

MSD International Holdings GmbH

Original Assignee

Schering Plough Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-13

Filing date

2005-08-10

Publication date

2009-02-12

2005-08-10 Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd

2009-02-12 Publication of DE602005012107D1 publication Critical patent/DE602005012107D1/de

Status Active legal-status Critical Current

2025-08-11 Anticipated expiration legal-status Critical

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/538—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with carbocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Dispersion Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)
Medicinal Preparation (AREA)

DE602005012107T 2004-08-13 2005-08-10 Pharmazeutische formulierungen mit einem antibioti Active DE602005012107D1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US60147504P	2004-08-13	2004-08-13
PCT/US2005/028379 WO2006020689A1 (en)	2004-08-13	2005-08-10	Pharmaceutical formulation comprising an antibiotic, a triazole and a corticosteroid

Publications (1)

Publication Number	Publication Date
DE602005012107D1 true DE602005012107D1 (de)	2009-02-12

Family

ID=35431350

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE602005012107T Active DE602005012107D1 (de)	2004-08-13	2005-08-10	Pharmazeutische formulierungen mit einem antibioti

Country Status (28)

Country	Link
US (2)	US8084445B2 (de)
EP (1)	EP1776109B1 (de)
JP (2)	JP4792032B2 (de)
KR (1)	KR101289115B1 (de)
CN (2)	CN101039668A (de)
AR (1)	AR050838A1 (de)
AT (1)	ATE418984T1 (de)
AU (1)	AU2005272925B2 (de)
BR (1)	BRPI0514098B1 (de)
CA (1)	CA2576589C (de)
DE (1)	DE602005012107D1 (de)
DK (1)	DK1776109T3 (de)
EC (1)	ECSP077239A (de)
ES (1)	ES2320360T3 (de)
HK (1)	HK1098368A1 (de)
IL (1)	IL181248A (de)
MX (1)	MX2007001811A (de)
MY (1)	MY145148A (de)
NO (1)	NO20073073L (de)
NZ (1)	NZ553119A (de)
PE (1)	PE20060489A1 (de)
PL (1)	PL1776109T3 (de)
PT (1)	PT1776109E (de)
RU (1)	RU2394573C2 (de)
TW (1)	TWI362261B (de)
UA (1)	UA89793C2 (de)
WO (1)	WO2006020689A1 (de)
ZA (1)	ZA200701253B (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE518540T1 (de) *	1999-08-16	2011-08-15	Revaax Pharmaceuticals Llc	Beta-lactam verbindung enthaltende neurotherapeutische zusammensetzung
US6426342B2 (en) *	1999-08-16	2002-07-30	Revaax Pharmaceuticals, Llc	Use of β-lactamase inhibitors as neuroprotectants
US8088820B2 (en) *	2001-04-24	2012-01-03	Paratek Pharmaceuticals, Inc.	Substituted tetracycline compounds for the treatment of malaria
PT1776109E (pt)	2004-08-13	2009-03-25	Schering Plough Ltd	Formulação farmacêutica que compreende um antibiótico, um triazol e um corticosteróide
DE102005055385A1 (de) *	2004-12-09	2006-06-14	Bayer Healthcare Ag	Arzneimittel zur hygienischen Applikation im Ohr
DE102006010643A1 (de) *	2006-03-08	2007-09-13	Bayer Healthcare Aktiengesellschaft	Arzneimittel enthaltend Fluorchinolone
DE102006010642A1 (de) *	2006-03-08	2007-09-27	Bayer Healthcare Aktiengesellschaft	Arzneimittelformulierungen, enthaltend Fluorchinolone
EP2015755A4 (de) *	2006-04-28	2010-02-24	Wockhardt Ltd	Verbesserung einer therapie zur behandlung von infektionen mit resistenten bakterien
WO2008002118A1 (es) *	2006-06-27	2008-01-03	Arturo Jimenez Bayardo	Una formulación oftálmica en suspensión de etabonato de loteprednol y clorhidrato de ciprofloxacina
BRPI0703127A2 (pt) *	2007-08-22	2009-04-14	Ouro Fino Participacoes E Empreendimentos Sa	composição para o tratamento de otites agudas ou crÈnicas causadas por fungos e/ou bactérias em animais de companhia
EP2214680A4 (de) *	2007-10-26	2010-12-29	Rexahn Pharmaceuticals Inc	Pharmazeutische formulierung von clavulansäure
US20090170954A1 (en) *	2007-12-14	2009-07-02	Schering-Plough Ltd.	Process for Recovering Florfenicol and Florfenicol Analogs
TW201010708A (en) *	2008-06-02	2010-03-16	Intervet Int Bv	Composition comprising an antibiotic and a corticosteroid
US8318817B2 (en) *	2008-07-21	2012-11-27	Otonomy, Inc.	Controlled release antimicrobial compositions and methods for the treatment of otic disorders
MX2011011459A (es) *	2009-04-29	2011-11-18	Rexahn Pharmaceuticals Inc	Formulacion de clavulanato para neuroproteccion y tratamiento de trastornos neurodegenerativos.
SI3391890T1 (sl) *	2010-06-29	2021-11-30	Merck Sharp & Dohme Corp.	Formulacije intravenske raztopine posakonazola, stabilizirane s substituiranim beta-ciklodekstrinom
CN103260466B (zh)	2010-12-20	2016-08-17	高露洁-棕榄公司	含有亲水性活性物质、疏水性结构化剂和油载体的明胶包囊的口腔护理组合物
BR112014012994A2 (pt) *	2011-11-30	2017-06-13	Toyama Chemical Co Ltd	tablete contendo hidrato de metanossulfonato do ácido 1-ciclopropil-8-(difluorometóxi)-7-[(1r)-1-metil-2,3-diidro-1h-isoindol-5-il]-4-oxo-1, 4-diidroquinolina-3-carboxílico
CA2890894C (en) *	2013-01-14	2019-06-11	Wockhardt Limited	Compositions and methods for treating bacterial infections
KR101473979B1 (ko) *	2013-01-18	2014-12-26	한국썸벧(주)	마보플록사신을 포함하는 약제학적 조성물
US9078853B2 (en)	2013-06-18	2015-07-14	Cmpd Licensing, Llc	Dry pharmaceutical compositions for topical delivery of oral medications, nasal delivery and to treat ear disorders
CN104606141A (zh) *	2013-11-01	2015-05-13	瑞普（天津）生物药业有限公司	一种替米考星肠溶微丸
CN104983718A (zh) *	2015-07-17	2015-10-21	江西博莱大药厂有限公司	一种替米考星缓释微丸及其制备方法和应用
CN105412123B (zh) *	2015-11-06	2018-03-13	山东省千佛山医院	布地奈德联合三唑类抗真菌药物的应用及其产品
WO2017091168A1 (en)	2015-11-28	2017-06-01	Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş.	A topical spray comprising isoconazole nitrate and difluocortolone valerate
US10525025B2 (en)	2016-11-17	2020-01-07	Cmpd Licensing, Llc	Compounded compositions and methods for treating pain
US10966946B2 (en)	2016-11-17	2021-04-06	Cmpd Licensing, Llc	Compounded compositions and methods for treating pain
US11986448B2 (en)	2016-11-17	2024-05-21	Cmpd Licensing, Llc	Compounded compositions and methods for treating pain
US11737975B2 (en)	2016-11-17	2023-08-29	Cmpd Licensing, Llc	Compounded compositions and methods for treating pain
US9999604B2 (en)	2016-11-17	2018-06-19	Cmpd Licensing, Llc	Compounded solutions of diclofenac and lidocaine and methods
CN109096307A (zh) *	2017-06-20	2018-12-28	赵建宇	一种33/4水头孢曲松钠化合物
EP3733176B1 (de) *	2017-12-25	2022-05-11	Xiangbei Welman Pharmaceutical Co., Ltd	Zusammensetzung mit piperacillin, pharmazeutisches präparat davon und verwendung davon
EP4041153A4 (de) *	2019-10-11	2023-10-25	Piedmont Animal Health Inc.	Ohrentherapeutische zusammensetzungen, verfahren und vorrichtungen
CN111166719A (zh) *	2019-12-31	2020-05-19	郑州都灵兽药科技有限公司	一种泰拉霉素肠溶颗粒的制备方法
CN112089695A (zh) *	2020-10-30	2020-12-18	康普药业股份有限公司	一种头孢克肟颗粒制剂及其制备方法
CA3239989A1 (en)	2021-12-20	2023-06-29	Intervet International B.V.	A pharmaceutical composition for the treatment of otic infections

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4141078A (en)	1975-10-14	1979-02-20	Innovated Systems, Inc.	Library circulation control system
ES8104203A1 (es)	1979-02-05	1981-04-16	Schering Corp	Un procedimiento para la preparacion de un compuesto d-(treo-1-aril-2-acilamido-3-fluor-1-propanol
US4235892A (en)	1979-02-05	1980-11-25	Schering Corporation, Patent Dept.	1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
NZ199808A (en)	1981-03-03	1986-06-11	Maciver K J A & Sons	Machine for renting video tape cassettes:individual compartment for each cassette
US4820695A (en)	1982-09-13	1989-04-11	Eli Lilly And Company	C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics
US4443430A (en)	1982-11-16	1984-04-17	Ethicon, Inc.	Synthetic absorbable hemostatic agent
IT1173213B (it)	1984-02-03	1987-06-18	Zambon Spa	Procedimento per fluorurare alcuni derivati dall'1l-fenil-2-ammino-1,3-propandiolo e loro intermedi
US5105009A (en)	1983-06-02	1992-04-14	Zambon S.P.A.	Intermediates for the preparation of 1-(phenyl)-1-hydroxy-2-amino-3-fluoropropane derivatives
US5332835A (en)	1984-02-03	1994-07-26	Zambon S.P.A.	Process for fluorinating 1-phenyl-2-amino-1,3-propanediol compounds and new oxazoline compounds useful in this process
US4582918A (en)	1984-09-19	1986-04-15	Schering Corporation	Preparation of intermediates for (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
US4973750A (en)	1984-09-19	1990-11-27	Schering Corporation	Preparation of (threo)-1-aryl-2-acylamido-3-fluoro-1-propanols
US4812629A (en)	1985-03-06	1989-03-14	Term-Tronics, Incorporated	Method and apparatus for vending
US5104868A (en)	1988-06-21	1992-04-14	Pfizer Inc.	Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters
US5095195A (en)	1988-08-03	1992-03-10	Thru-The-Wall Corporation	Automated videocassette dispensing terminal with reservation feature
US5594228A (en)	1988-08-25	1997-01-14	Symbol Technologies, Inc.	Self-checkout, point-of-transaction system including deactivatable electro-optically coded surveillance tags
US5227494A (en)	1988-09-14	1993-07-13	Schering Corporation	Process for preparing oxazoline compounds
US4876352A (en)	1988-09-14	1989-10-24	Schering Corporation	Pressurized fluorination of hydroxy alkyl groups
CA2001203C (en)	1988-10-24	2001-02-13	Thomas P. Demuth, Jr.	Novel antimicrobial dithiocarbamoyl quinolones
US5491139A (en)	1988-10-24	1996-02-13	The Procter & Gamble Company	Antimicrobial quinolonyl lactams
US5007518A (en)	1989-02-13	1991-04-16	Sam Crivello	Apparatus for renting articles
US5198220A (en)	1989-11-17	1993-03-30	The Procter & Gamble Company	Sustained release compositions for treating periodontal disease
ATE193890T1 (de)	1990-04-18	2000-06-15	Procter & Gamble Pharma	Antimikrobielle chinolonyl-lactame
RU2071468C1 (ru)	1990-10-25	1997-01-10	Шеринг Корпорейшн	Способ получения [r-(r,s)]-2,2-дихлор-n-1(фторметил)-2-гидрокси-2-[4-(метилсульфонил)-фенил]-этилацетамида и способ получения д-(-)-трео-2-(дихлорметил)-4,5-дигидро-5-[4-(метилсульфонил)-фенил]-4-оксазолметанола
US5242910A (en)	1992-10-13	1993-09-07	The Procter & Gamble Company	Sustained release compositions for treating periodontal disease
US5646163A (en)	1992-10-30	1997-07-08	The Procter & Gamble Company	Quinolone 5-(N-heterosubstituted amino) antimicrobials
US5352832A (en)	1992-12-18	1994-10-04	Schering Corporation	Asymmetric process for preparing florfenicol, thiamphenicol chloramphenicol and oxazoline intermediates
KR0148277B1 (ko)	1993-01-18	1998-11-02	채영복	신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
AU4272793A (en)	1993-04-24	1994-11-21	Korea Research Institute Of Chemical Technology	Novel quinolone carboxylic acid derivatives and process for preparing the same
AU679961B2 (en)	1993-08-13	1997-07-17	Dong Wha Pharmaceutical Industrial Co., Ltd.	Novel quinolone carboxylic acid derivatives
FR2711524B1 (fr)	1993-10-21	1995-11-24	Rhone Dpc Europ	Procédé de préparation de compositions orales contenant des quinolones.
CA2175804C (en)	1993-11-04	2003-02-25	Peter Y. Zhou	Method and apparatus for automatically desensitizing sensor elements
US5661151A (en) *	1993-12-21	1997-08-26	Schering Corporation	Tetrahydrofuran antifungals
CN1064685C (zh) *	1993-12-21	2001-04-18	先灵公司	四氢呋喃抗真菌剂
CZ138297A3 (en)	1994-11-18	1997-10-15	Pharmacia & Upjohn	Novel physically stable form of solid fluoroquinolone
US5777884A (en)	1995-10-16	1998-07-07	Minnesota Mining And Manufacturing Company	Article inventory tracking and control system
US5834472A (en)	1996-05-24	1998-11-10	Schering Corporation	Antifungal composition with enhanced bioavailability
US5846971A (en)	1996-06-28	1998-12-08	Schering Corporation	Oral antifungal composition
US5663361A (en)	1996-08-19	1997-09-02	Schering Corporation	Process for preparing intermediates to florfenicol
US5990794A (en) *	1996-09-26	1999-11-23	Sensormatic Electronics Corporation	Apparatus for data communication and deactivation of electronic article surveillance tags
JP3892085B2 (ja)	1996-10-04	2007-03-14	東興薬品工業株式会社	動物用点耳クリーム剤
US6025780A (en)	1997-07-25	2000-02-15	Checkpoint Systems, Inc.	RFID tags which are virtually activated and/or deactivated and apparatus and methods of using same in an electronic security system
US20020052390A1 (en) *	1997-10-22	2002-05-02	Jens Ponikau	Methods and materials for treating and preventing inflammation of mucosal tissue
SG122782A1 (en) *	1998-08-14	2006-06-29	3M Innovative Properties Co	Applications for radio frequency identification systems
MY133181A (en) *	1998-09-10	2007-10-31	Schering Corp	Methods and compositions for treating sinusitis, otitis media and other related disorders using antihistamines
US6169483B1 (en)	1999-05-04	2001-01-02	Sensormatic Electronics Corporation	Self-checkout/self-check-in RFID and electronics article surveillance system
US6333692B1 (en)	1999-07-06	2001-12-25	Ats Money Systems Inc.	Security tag deactivation system
US20020067267A1 (en) *	2000-03-15	2002-06-06	Richard Kirkham	Package identification system
CN1137899C (zh)	2000-03-16	2004-02-11	上海华联制药有限公司	17,21-酯取代的1,4-二烯-3-酮-9,11-环氧甾体化合物
WO2001089495A2 (en)	2000-05-19	2001-11-29	Alcon Laboratories, Inc.	Antibiotic compositions containing quinolone derivatives for treatment of the eye, ear and nose
CA2412376A1 (en) *	2000-07-26	2002-01-31	Onkar N. Singh	Pharmaceutical suspension compositions lacking a polymeric suspending agent
JP4104463B2 (ja)	2001-04-27	2008-06-18	ファイザー・プロダクツ・インク	４’’−置換された−９−デオキソ−９ａ−アザ−９ａ−ホモエリスロマイシン誘導体を製造するための方法
CA2459930C (en) *	2001-09-21	2009-11-10	Alcon, Inc.	Method of treating middle ear infections
MXPA05003124A (es)	2002-09-23	2005-06-22	Schering Corp	Uso de posaconazol para el tratamiento de infecciones fungales.
US20050159369A1 (en) *	2003-08-20	2005-07-21	Qtm Llc	Method of treatment of otitis externa
PT1776109E (pt)	2004-08-13	2009-03-25	Schering Plough Ltd	Formulação farmacêutica que compreende um antibiótico, um triazol e um corticosteróide
TW201010708A (en)	2008-06-02	2010-03-16	Intervet Int Bv	Composition comprising an antibiotic and a corticosteroid

2005
- 2005-08-10 PT PT05786782T patent/PT1776109E/pt unknown
- 2005-08-10 PE PE2005000927A patent/PE20060489A1/es not_active Application Discontinuation
- 2005-08-10 US US11/201,044 patent/US8084445B2/en active Active
- 2005-08-10 JP JP2007525752A patent/JP4792032B2/ja active Active
- 2005-08-10 AT AT05786782T patent/ATE418984T1/de active
- 2005-08-10 WO PCT/US2005/028379 patent/WO2006020689A1/en active Application Filing
- 2005-08-10 NZ NZ553119A patent/NZ553119A/en not_active IP Right Cessation
- 2005-08-10 MX MX2007001811A patent/MX2007001811A/es active IP Right Grant
- 2005-08-10 PL PL05786782T patent/PL1776109T3/pl unknown
- 2005-08-10 CN CNA2005800351223A patent/CN101039668A/zh active Pending
- 2005-08-10 AU AU2005272925A patent/AU2005272925B2/en active Active
- 2005-08-10 MY MYPI20053727A patent/MY145148A/en unknown
- 2005-08-10 BR BRPI0514098-6A patent/BRPI0514098B1/pt active IP Right Grant
- 2005-08-10 CN CN2011102914653A patent/CN102499928A/zh active Pending
- 2005-08-10 KR KR1020077003332A patent/KR101289115B1/ko not_active IP Right Cessation
- 2005-08-10 ES ES05786782T patent/ES2320360T3/es active Active
- 2005-08-10 CA CA2576589A patent/CA2576589C/en active Active
- 2005-08-10 DE DE602005012107T patent/DE602005012107D1/de active Active
- 2005-08-10 RU RU2007108875/15A patent/RU2394573C2/ru active
- 2005-08-10 EP EP05786782A patent/EP1776109B1/de active Active
- 2005-08-10 UA UAA200702668A patent/UA89793C2/uk unknown
- 2005-08-10 DK DK05786782T patent/DK1776109T3/da active
- 2005-08-11 TW TW094127341A patent/TWI362261B/zh not_active IP Right Cessation
- 2005-08-11 AR ARP050103355A patent/AR050838A1/es not_active Application Discontinuation
2007
- 2007-02-08 IL IL181248A patent/IL181248A/en not_active IP Right Cessation
- 2007-02-12 EC EC2007007239A patent/ECSP077239A/es unknown
- 2007-02-12 ZA ZA200701253A patent/ZA200701253B/en unknown
- 2007-05-07 HK HK07104854.0A patent/HK1098368A1/xx unknown
- 2007-06-15 NO NO20073073A patent/NO20073073L/no not_active Application Discontinuation
2011
- 2011-06-15 JP JP2011133720A patent/JP2011178811A/ja not_active Withdrawn
- 2011-11-10 US US13/293,994 patent/US8609645B2/en active Active

Also Published As

Publication number	Publication date
IL181248A0 (en)	2007-07-04
US8084445B2 (en)	2011-12-27
TWI362261B (en)	2012-04-21
CN102499928A (zh)	2012-06-20
US20120058964A1 (en)	2012-03-08
NZ553119A (en)	2010-11-26
HK1098368A1 (en)	2007-07-20
US8609645B2 (en)	2013-12-17
ZA200701253B (en)	2008-07-30
BRPI0514098B1 (pt)	2021-01-19
JP4792032B2 (ja)	2011-10-12
WO2006020689A1 (en)	2006-02-23
AR050838A1 (es)	2006-11-29
EP1776109B1 (de)	2008-12-31
MX2007001811A (es)	2007-03-26
PT1776109E (pt)	2009-03-25
AU2005272925B2 (en)	2011-02-10
RU2394573C2 (ru)	2010-07-20
DK1776109T3 (da)	2009-05-04
EP1776109A1 (de)	2007-04-25
PE20060489A1 (es)	2006-06-19
PL1776109T3 (pl)	2009-06-30
KR101289115B1 (ko)	2013-07-23
CA2576589A1 (en)	2006-02-23
ATE418984T1 (de)	2009-01-15
IL181248A (en)	2014-07-31
NO20073073L (no)	2007-06-15
JP2008509913A (ja)	2008-04-03
ES2320360T3 (es)	2009-05-21
UA89793C2 (uk)	2010-03-10
US20060122159A1 (en)	2006-06-08
CN101039668A (zh)	2007-09-19
KR20070041571A (ko)	2007-04-18
TW200621238A (en)	2006-07-01
ECSP077239A (es)	2007-03-29
CA2576589C (en)	2013-11-12
AU2005272925A1 (en)	2006-02-23
BRPI0514098A (pt)	2008-05-27
MY145148A (en)	2011-12-30
RU2007108875A (ru)	2008-09-20
JP2011178811A (ja)	2011-09-15

Publication	Publication Date	Title
DE602005012107D1 (de)	2009-02-12	Pharmazeutische formulierungen mit einem antibioti
DE60316323D1 (de)	2007-10-25	Feste pharmazeutische formulierungen mit telmisartan
DE602004025950D1 (de)	2010-04-22	Pharmazeutische formulierung mit lanthanum-verbindungen
DE602004016444D1 (de)	2008-10-23	Azithromycin enthaltende pharmazeutische Zusammensetzungen mit verringerten Nebenwirkungen
ATE447396T1 (de)	2009-11-15	Pharmazeutisches vaginales gel mit tenofovir
NO20075628L (no)	2007-11-05	Farmasøytiske formuleringer
ITBO20050123A1 (it)	2005-06-06	Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
BRPI0511900A (pt)	2008-01-22	composições farmacêuticas
DK3437682T3 (da)	2022-05-16	Lægemiddeladministrationsanordning
DE602004016967D1 (de)	2008-11-20	Flüssige pharmazeutische palonosetronformulierungen
DE602004017700D1 (de)	2008-12-24	Transmukosen verabreichung
DK1587478T3 (da)	2013-10-21	Farmaceutisk sammensætning
DE60305728D1 (de)	2006-07-06	PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT VERLuNGERTER FREISETZUNG
ATE415949T1 (de)	2008-12-15	Pharmazeutische formulierung mit levothyroxin- natrium
DE602004024220D1 (de)	2009-12-31	Pharmazeutische modafinil-zusammensetzungen mit modifizierter freisetzung
DK1757293T3 (da)	2012-10-22	Bh4-responsiv hyperphenylalaninæmi-medikamenter
DE60336999D1 (de)	2011-06-16	Melatonin enthaltende pharmazeutische formulierung
DE602006017975D1 (de)	2010-12-16	Feste pharmazeutische zusammensetzung mit telithromycin
ATE546141T1 (de)	2012-03-15	Pharmazeutisches injektionspräparat
DK2918286T3 (da)	2020-03-30	En farmaceutisk formulering
DE602006018617D1 (de)	2011-01-13	Pharmazeutische zusammensetzung mit 2,3-dihydro-6-nitroimidazoä2,1-büoxazolderivaten
IS7290A (is)	2005-11-29	Lyfjasamsetningar sem innihalda risperidone
DK1784174T3 (da)	2012-12-10	Famaceutisk sammensætning omfattende gabapentin
ITMI20040943A1 (it)	2004-08-11	Composizione farmaceutica cicatrizzante
DE602005005033D1 (de)	2008-04-10	Sprühgetrocknete pharmazeutische zusammensetzungen

Legal Events

Date	Code	Title	Description
2010-01-21	8364	No opposition during term of opposition